Clinical Manifestations and Risk Factors Influencing Eradication of Extensive Multidrug-resistant Acinetobacter baumannii from the Respiratory Tract

Medicine and Dentistry

• Combination Therapy 100%
• Tigecycline 100%
• Acinetobacter Baumannii 100%
• Colistimethate 100%
• Mortality Rate 50%
• Medical Record 50%
• Clinician 50%
• Drug Megadose 50%
• Low Drug Dose 50%
• Long-Term Care 50%
• Artificial Respiration 50%
• Hospital Mortality 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Respiratory Tract 100%
• Acinetobacter Baumannii 100%
• Combination Therapy 50%
• Tigecycline 50%
• Colistimethate 50%
• Mortality Rate 25%
• Hospital Mortality 25%